Page last updated: 2024-08-17

galactose and Pulmonary Aspergillosis

galactose has been researched along with Pulmonary Aspergillosis in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (6.25)	29.6817
2010's	35 (72.92)	24.3611
2020's	10 (20.83)	2.80

Authors

Authors	Studies
Li, S; Li, Z; Liu, W; Su, D; Tang, C; Ye, F; Zeng, P; Zhan, Y	1
Afeltra, J; Alvarez, C; Cabeza, MS; Farías, L; Fernández, NB; Garcia-Effron, G; Giuliano, CV; Giusiano, G; Noblega, LM; Ochiuzzi, ME; Santiso, G; Tracogna, F; Vitale, RG	1
Abastabar, M; Arastehfar, A; Davoodi, L; Ghazanfari, M; Haghani, I; Hedayati, MT; Hoenigl, M; Mayahi, S; Moazeni, M; Pan, W; Yazdani Charati, J	1
Agarwal, R; Aggarwal, AN; Chakrabarti, A; Choudhary, H; Dhooria, S; Garg, M; Sehgal, IS	4
Lai, G; Mo, J; Song, WD; Xu, P; Zeng, C	1
Böll, B; Böttiger, BW; Cornely, OA; Dusse, F; Eichenauer, DA; Fuchs, F; Hallek, M; Jung, N; Klein, F; Kochanek, M; Koehler, P; Persigehl, T; Rybniker, J; Shimabukuro-Vornhagen, A	1
Attou, R; Barreto Gutierrez, L; De Bels, D; Gallerani, A; Honore, PM; Kugener, L; Redant, S	1
Azoulay, E; Bassetti, M; Blot, S; Brüggemann, RJM; Calandra, T; Chiller, T; Clancy, CJ; Cornely, OA; Depuydt, P; Giacobbe, DR; Janssen, NAF; Kullberg, BJ; Lagrou, K; Lass-Flörl, C; Lewis, RE; Liu, PW; Lortholary, O; Maertens, J; Martin-Loeches, I; Nguyen, MH; Patterson, TF; Rijnders, BJA; Rogers, TR; Schouten, JA; Spriet, I; van de Veerdonk, FL; Vanderbeke, L; Verweij, PE; Wauters, J	1
du Mée, AWF; Flikweert, AW; Grootenboers, MJJH; Kant, MKM; Rettig, TCD; van der Meer, NJM; Yick, DCY	1
Cervantes-Sanchez, A; Diaz-Lomelí, P; Gonzalez-Lara, MF; Martinez-Gamboa, A; Ponce-de-Leon, A; Rangel-Cordero, A; Roman-Montes, CM; Sifuentes-Osornio, J	1
Chen, Z; Hu, M; Tan, L; Wang, L; Wu, J; Wu, Z	1
Hebisawa, A; Homma, S; Ishii, Y; Koyama, K; Nakamura, Y; Sakamoto, S; Sano, G; Suzuki, J; Tateda, K; Urabe, N	1
Denning, DW; Fayemiwo, S; Foden, P; Moore, CB; Richardson, MD	1
Bogdan, C; Held, J; Melichar, VO; Meyer, R; Rauh, M; Träger, J	1
Farmakiotis, D; Ismail, N; Koo, S; Kubiak, DW; Le, A; Weiss, Z	1
Hoenigl, M; Jenks, JD; Salzer, HJF	1
Aniwidyaningsih, W; Burhan, E; Hagen, F; Handayani, D; Jayusman, AM; Jusuf, A; Meis, JF; Prasenohadi, P; Prihartono, J; Rozaliyani, A; Rumende, CM; Rusli, A; Sedono, R; Siagian, FE; Sungkar, S; Wahyuningsih, R; Yunihastuti, E	1
Alanio, A; Bretagne, S; Chowdhary, A; Colley, T; Daly, L; Ito, K; Kimura, G; Kizawa, Y; Meis, JF; Nakaoki, T; Nishimoto, Y; Rapeport, G; Sharma, C; Strong, P	1
Denning, DW; Li, C; Li, Y; Liu, Y; Ma, X; Wang, K; Xie, L; Yu, X; Zhao, X	1
Fujiwara, A; Kasagi, S; Kono, Y; Kurita, N; Setoguchi, Y; Soeda, S; Sugiyama, S; To, M; To, Y; Togashi, Y; Tsushima, K; Yamaguchi, K	1
Yoshida, M	1
Ali, S; Bhargava, R; Malik, A; Shahid, M	1
Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M	1
Jeon, K; Jeong, BH; Koh, WJ; Kwon, OJ; Park, HY; Shin, B; Suh, GY; Yoo, H	1
Beyene, J; Chellapandian, D; Fisher, BT; Lehrnbecher, T; Phillips, B; Steinbach, WJ; Sung, L; Zaoutis, TE	1
Gils, S; Lagrou, K; Maertens, J	1
Buitrago, MJ; Cendejas-Bueno, E; Forastiero, A; Gavaldà, J; Gomez-Lopez, A; Mellado, E; Ruiz, I	1
Chan, JF; Chan, SM; Cheng, VC; Hung, IF; Lau, SK; Leung, SS; Pang, CM; So, SY; To, KK; Wong, SC; Woo, PC; Xiao, C; Yuen, KY	1
Christner, M; Fuhrmann, V; Katchanov, J; Kluge, S; Laqmani, A; Rohde, H; Schroeder, M; Simon, M; Wichmann, D; Wijaya, C	1
Fujikane, T; Fujit, Y; Fujiuchi, S; Nishigaki, Y; Ohsaki, Y; Osanai, S; Takeda, A; Yamamoto, Y; Yamazaki, Y	1
Maertens, J; Meersseman, W; Van Bleyenbergh, P	1
Avila, NA; Bacher, J; Cotton, MP; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Meletiadis, J; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ	1
Arnulf, B; Belle, A; Bergeron, A; Chevret, S; Lacroix, C; Raffoux, E; Ribaud, P; Socié, G; Sulahian, A; Tazi, A	1
Chen, YQ; Guo, YL; Kong, JL; Qin, SM; Wang, K; Wu, C	1
Ahmad, S; Burhamah, MHA; Khan, ZU; Mokaddas, E	1
Camus, C; Gangneux, JP; Philippe, B	1
Choi, CM; Choi, SH; Hong, SB; Jeong, JY; Kim, DS; Kim, MN; Kim, SH; Kim, YS; Koh, Y; Lee, SO; Lim, CM; Oh, YM; Park, SY; Shim, TS; Sung, H; Woo, JH	1
Antonelli, M; Bello, G; Caira, M; De Carolis, E; De Pascale, G; Fadda, G; Fuso, L; Moody, A; Pagano, L; Posteraro, B; Sanguinetti, M; Torelli, R	1
Datry, A; Elsendoorn, A; Fekkar, A; Godet, C; Herbrecht, R; Kauffmann-Lacroix, C; Letscher-Bru, V; Massias, L; Nivoix, Y; Pang, KA; Scholler, J; Uzunov, M	1
Fortún, J; Fresco, G; Meije, Y; Moreno, S	1
Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Mine, M; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A	1
Bertz, H; Buchheidt, D; Heinz, WJ; Hofmann, WK; Kiehl, M; Krause, SW; Lass-Flörl, C; Maschmeyer, G; Reinwald, M; Schultheis, B; Spiess, B; Vehreschild, JJ; Wolf, HH	1
Campo, S; De Santis, R; Lo Giudice, P; Salvatori, G	1
Hu, H; Ju, YF; Teng, GL; Wei, M; Yang, Y; Zhang, LL	1

Reviews

7 review(s) available for galactose and Pulmonary Aspergillosis

Article	Year
Improving the rates of Aspergillus detection: an update on current diagnostic strategies. Expert review of anti-infective therapy, 2019, Volume: 17, Issue:1 Topics: Animals; Aspergillosis; Aspergillus; Biomarkers; Chronic Disease; Galactose; Humans; Magnetic Resonance Imaging; Mannans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Pulmonary Aspergillosis	2019
[Serological diagnosis for invasive fungal infections]. Medical mycology journal, 2013, Volume: 54, Issue:2 Topics: Antigens, Fungal; beta-Glucans; Candidiasis, Invasive; Galactose; Humans; Mannans; Mycoses; Proteoglycans; Pulmonary Aspergillosis; Serologic Tests	2013
Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Feb-10, Volume: 33, Issue:5 Topics: Adult; Aspergillus; Biomarkers; Biopsy; Bronchoalveolar Lavage; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Lung; Lung Diseases; Lung Neoplasms; Mannans; Neoplasms; Pneumonia; Polymerase Chain Reaction; Pulmonary Aspergillosis	2015
New therapies for fungal pneumonia. Current opinion in infectious diseases, 2009, Volume: 22, Issue:2 Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole	2009
Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest, 2010, Volume: 138, Issue:4 Topics: Biomarkers; Bronchoalveolar Lavage Fluid; Galactose; Humans; Mannans; Predictive Value of Tests; Pulmonary Aspergillosis; ROC Curve; Sensitivity and Specificity	2010
Epidemiology of invasive aspergillosis and risk factors in non neutropaenic patients. Revue des maladies respiratoires, 2010, Volume: 27, Issue:8 Topics: AIDS-Related Opportunistic Infections; Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Chronic Disease; Fungemia; Galactose; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases; Mannans; Neutropenia; Organ Transplantation; Postoperative Complications; Pulmonary Aspergillosis; Radiography; Respiratory System; Risk Factors; Wound Infection	2010
[Aspergillosis. Clinical forms and treatment]. Enfermedades infecciosas y microbiologia clinica, 2012, Volume: 30, Issue:4 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cross Infection; Drug Resistance, Multiple, Fungal; Endocarditis; Endophthalmitis; Fungemia; Galactose; Humans; Immunocompromised Host; Mannans; Neuroaspergillosis; Postoperative Complications; Pulmonary Aspergillosis; Radiography; Risk Factors; Salvage Therapy; Species Specificity; Vulnerable Populations	2012

Trials

4 trial(s) available for galactose and Pulmonary Aspergillosis

Article	Year
Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis. BMC infectious diseases, 2019, Aug-06, Volume: 19, Issue:1 Topics: Adult; Aged; Antibodies, Fungal; Aspergillus; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Immunoglobulin Isotypes; Male; Mannans; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; ROC Curve; Sensitivity and Specificity	2019
Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study. Critical care (London, England), 2016, May-10, Volume: 20, Issue:1 Topics: Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Galactose; Humans; Intensive Care Units; Mannans; Prospective Studies; Pulmonary Aspergillosis; Therapeutic Irrigation	2016
Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples. European journal of haematology, 2012, Volume: 89, Issue:2 Topics: Adolescent; Adult; Aged; Aspergillus; Bronchoalveolar Lavage; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Pulmonary Aspergillosis; Sensitivity and Specificity	2012
[Application of detecting bronchoalveolar lavage fluid Aspergillus galactomannan antigen in the diagnosis of pulmonary aspergillosis]. Zhonghua yi xue za zhi, 2012, Aug-28, Volume: 92, Issue:32 Topics: Adult; Aged; Antigens, Fungal; Bronchoalveolar Lavage Fluid; Female; Galactose; Humans; Male; Mannans; Middle Aged; Predictive Value of Tests; Pulmonary Aspergillosis; Sensitivity and Specificity	2012

Other Studies

37 other study(ies) available for galactose and Pulmonary Aspergillosis

Article	Year
Detection of Annals of clinical and laboratory science, 2021, Volume: 51, Issue:5 Topics: Adult; Aged; Antigens, Bacterial; Aspergillus; Bronchoalveolar Lavage Fluid; Chronic Disease; DNA, Bacterial; Early Diagnosis; Female; Galactose; Humans; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Aspergillosis; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity	2021
Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina. Medical mycology, 2022, May-18, Volume: 60, Issue:5 Topics: Animals; Argentina; Aspergillus; COVID-19; Critical Illness; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Prospective Studies; Pulmonary Aspergillosis; Sensitivity and Specificity	2022
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis. Mycoses, 2022, Volume: 65, Issue:10 Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; COVID-19; COVID-19 Testing; Galactose; Humans; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Mannans; Pulmonary Aspergillosis; Sensitivity and Specificity	2022
Efficiency of A fumigatus-specific IgG and galactomannan testing in the diagnosis of simple aspergilloma. Mycoses, 2019, Volume: 62, Issue:12 Topics: Adult; Antibodies, Fungal; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Female; Galactose; Humans; Immunoglobulin G; Male; Mannans; Middle Aged; Pulmonary Aspergillosis; ROC Curve; Sensitivity and Specificity; Serologic Tests; Tomography, X-Ray Computed	2019
Diagnostic Value of Galactomannan in Bronchoalveolar Lavage Fluid for Chronic Respiratory Disease with Pulmonary Aspergillosis. Journal of clinical microbiology, 2020, 02-24, Volume: 58, Issue:3 Topics: Adult; Aged; Aspergillus; Biopsy; Bronchoalveolar Lavage Fluid; Bronchoscopy; China; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Male; Mannans; Middle Aged; Pulmonary Aspergillosis; ROC Curve; Sensitivity and Specificity; Young Adult	2020
COVID-19 associated pulmonary aspergillosis. Mycoses, 2020, Volume: 63, Issue:6 Topics: Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Female; Galactose; Germany; Hemorrhage; Hospitals, Teaching; Humans; Intensive Care Units; Lung Diseases; Male; Mannans; Metapneumovirus; Middle Aged; Nitriles; Pandemics; Paramyxoviridae Infections; Pneumonia, Viral; Pulmonary Aspergillosis; Pyridines; Respiratory Distress Syndrome; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Triazoles; Voriconazole	2020
Detecting influenza-associated pulmonary aspergillosis by determination of galactomannan in broncho-alveolar lavage fluid and in serum: should we add (1,3)-beta-D-glucan to improve efficacy. Critical care (London, England), 2020, 06-05, Volume: 24, Issue:1 Topics: beta-Glucans; Bronchoalveolar Lavage Fluid; Europe; Galactose; Humans; Influenza, Human; Intensive Care Units; Mannans; Proteoglycans; Pulmonary Aspergillosis; Surveys and Questionnaires	2020
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive care medicine, 2020, Volume: 46, Issue:8 Topics: Antifungal Agents; Aspergillus; Betacoronavirus; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Galactose; Humans; Influenza, Human; Intensive Care Units; Mannans; Pandemics; Pneumonia, Viral; Pulmonary Aspergillosis; SARS-CoV-2	2020
Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series. Journal of critical care, 2020, Volume: 59 Topics: Aged; Aged, 80 and over; Autopsy; Betacoronavirus; Biopsy; Biopsy, Large-Core Needle; Bronchoalveolar Lavage Fluid; Coinfection; Coronavirus Infections; COVID-19; Critical Illness; Female; Galactose; Humans; Lung; Lung Diseases, Interstitial; Male; Mannans; Middle Aged; Pandemics; Phenotype; Pneumonia, Viral; Pulmonary Aspergillosis; Pulmonary Embolism; Respiratory Distress Syndrome; SARS-CoV-2; Tomography, X-Ray Computed	2020
Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis. Mycoses, 2021, Volume: 64, Issue:4 Topics: Adult; Antifungal Agents; COVID-19; Diabetes Complications; Female; Galactose; Humans; Male; Mannans; Middle Aged; Obesity; Pulmonary Aspergillosis; Sensitivity and Specificity; Trachea	2021
Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients. Diagnostic microbiology and infectious disease, 2021, Volume: 99, Issue:4 Topics: Aged; Bronchoalveolar Lavage Fluid; Female; Galactose; Humans; Male; Mannans; Middle Aged; Pulmonary Aspergillosis	2021
Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis. Journal of clinical microbiology, 2017, Volume: 55, Issue:6 Topics: Aged; Aged, 80 and over; Aspergillus; beta-Glucans; Bronchoalveolar Lavage Fluid; Diagnostic Tests, Routine; Female; Galactose; Humans; Immunoassay; Male; Mannans; Middle Aged; Polymerase Chain Reaction; Predictive Value of Tests; Proteoglycans; Pulmonary Aspergillosis; Sensitivity and Specificity	2017
Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA. Journal of microbiological methods, 2017, Volume: 140 Topics: Adult; Aged; Aged, 80 and over; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Biomarkers; Bronchoalveolar Lavage Fluid; Chronic Disease; DNA, Fungal; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Male; Mannans; Middle Aged; Polymerase Chain Reaction; Pulmonary Aspergillosis; Retrospective Studies; ROC Curve; Sputum	2017
Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study. BMC pulmonary medicine, 2018, Mar-27, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aspergillus fumigatus; beta-Glucans; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Culture Techniques; Cystic Fibrosis; Female; Forced Expiratory Volume; Galactose; Humans; Male; Mannans; Middle Aged; Multivariate Analysis; Proteoglycans; Pulmonary Aspergillosis; Retrospective Studies; Sputum; Young Adult	2018
Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis. Mycoses, 2018, Volume: 61, Issue:10 Topics: Adult; Aged; Antibodies, Fungal; Aspergillus fumigatus; Chronic Disease; Female; Galactose; Humans; Immunoglobulin G; Male; Mannans; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Radiography, Thoracic; ROC Curve; Sensitivity and Specificity	2018
False positive bronchoalveolar lavage galactomannan: Effect of host and cut-off value. Mycoses, 2019, Volume: 62, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bronchoalveolar Lavage Fluid; Clinical Laboratory Techniques; False Positive Reactions; Female; Galactose; Hematologic Neoplasms; Humans; Mannans; Middle Aged; Organ Transplantation; Predictive Value of Tests; Pulmonary Aspergillosis; Retrospective Studies; Young Adult	2019
Utility of Serum and Bronchoalveolar Lavage Fluid Galactomannan in Diagnosis of Chronic Pulmonary Aspergillosis. Journal of clinical microbiology, 2019, Volume: 57, Issue:3 Topics: Adult; Aspergillus; Bronchoalveolar Lavage Fluid; Chronic Disease; Female; Fungal Polysaccharides; Galactose; Humans; Male; Mannans; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; ROC Curve; Sensitivity and Specificity; Serum	2019
Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019, Volume: 25, Issue:9 Topics: Adult; Antibodies, Fungal; Antifungal Agents; Azoles; Body Weight; Chronic Disease; Female; Follow-Up Studies; Galactose; Humans; Immunoglobulin G; Lung; Male; Mannans; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Treatment Outcome	2019
A novel diagnosis scoring model to predict invasive pulmonary aspergillosis in the intensive care unit. Saudi medical journal, 2019, Volume: 40, Issue:2 Topics: Adrenal Cortex Hormones; Case-Control Studies; Galactose; Humans; Incidence; Indonesia; Intensive Care Units; Mannans; Middle Aged; Neoplasms; Predictive Value of Tests; Pulmonary Aspergillosis; Risk Factors; Tuberculosis, Pulmonary	2019
Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus. The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10 Topics: Animals; Antifungal Agents; Aspergillus; Colony Count, Microbial; Disease Models, Animal; France; Galactose; Humans; India; Lung; Mannans; Mice; Microbial Sensitivity Tests; Netherlands; Pulmonary Aspergillosis; Treatment Outcome; Triazoles	2019
The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis. Respiratory medicine, 2013, Volume: 107, Issue:7 Topics: Aged; Antigens, Fungal; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Biomarkers; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Bronchoscopy; Female; Galactose; Humans; Male; Mannans; Middle Aged; Pulmonary Aspergillosis; Sensitivity and Specificity	2013
Pulmonary aspergillosis and aflatoxins in chronic lung diseases. Mycopathologia, 2013, Volume: 176, Issue:3-4 Topics: Aflatoxins; Aspergillus; Bronchoalveolar Lavage Fluid; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Humans; Male; Mannans; Microbiological Techniques; Microscopy; Middle Aged; Pulmonary Aspergillosis; Serum	2013
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species. Mycopathologia, 2014, Volume: 177, Issue:1-2 Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole	2014
Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis. The Journal of infection, 2014, Volume: 68, Issue:5 Topics: Aged; Antigens, Fungal; Biomarkers; Chronic Disease; Female; Galactose; Humans; Male; Mannans; Middle Aged; Predictive Value of Tests; Pulmonary Aspergillosis; Sensitivity and Specificity; Serologic Tests; Serum	2014
Pretreatment of Bronchoalveolar Lavage Fluid Samples with SLsolution Leads to False-Negative Aspergillus Galactomannan Levels. Journal of clinical microbiology, 2016, Volume: 54, Issue:4 Topics: Antigens, Fungal; Bronchoalveolar Lavage Fluid; False Negative Reactions; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Specimen Handling	2016
Galactomannan enzyme immunoassay and quantitative Real Time PCR as tools to evaluate the exposure and response in a rat model of aspergillosis after posaconazole prophylaxis. Enfermedades infecciosas y microbiologia clinica, 2016, Volume: 34, Issue:9 Topics: Animals; Antifungal Agents; Biomarkers; Galactose; Immunoenzyme Techniques; Mannans; Pulmonary Aspergillosis; Rats; Real-Time Polymerase Chain Reaction; Triazoles	2016
A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis. Emerging microbes & infections, 2016, Apr-20, Volume: 5 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Fungal; Aspergillus; Child; Chronic Disease; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Microbiological Techniques; Middle Aged; Prognosis; Pulmonary Aspergillosis; Survival Rate; Time Factors; Young Adult	2016
Term 11. Medical mycology journal, 2016, Volume: 57, Issue:3 Topics: Antigens; Biomarkers; Bronchoalveolar Lavage Fluid; Chromatography, Affinity; Cryptococcosis; Galactose; Humans; Latex Fixation Tests; Mannans; Polysaccharides; Pulmonary Aspergillosis	2016
[Evaluation of galactomannan antigen and beta-D-glucan value for diagnosis of chronic necrotizing pulmomary aspergillosis]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:1 Topics: Antigens, Bacterial; beta-Glucans; Chronic Disease; Galactose; Humans; Mannans; Necrosis; Proteoglycans; Pulmonary Aspergillosis; Sensitivity and Specificity	2009
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole	2009
Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest, 2010, Volume: 137, Issue:2 Topics: Adult; Antigens; Bronchoalveolar Lavage Fluid; Bronchoscopy; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Pulmonary Aspergillosis; Reproducibility of Results; Retrospective Studies; Severity of Illness Index	2010
Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis. Journal of medical microbiology, 2010, Volume: 59, Issue:Pt 12 Topics: Antifungal Agents; beta-Glucans; Child; Galactose; Humans; Lung Diseases, Fungal; Male; Mannans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteoglycans; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole	2010
Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Apr-01, Volume: 52, Issue:7 Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Clinical Laboratory Techniques; Female; Galactose; Humans; Male; Mannans; Middle Aged; Pulmonary Aspergillosis; Sensitivity and Specificity; Serum	2011
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. Journal of clinical microbiology, 2011, Volume: 49, Issue:12 Topics: Aspergillus; Bacteriological Techniques; Bronchoalveolar Lavage Fluid; Galactose; Humans; Immunoenzyme Techniques; Mannans; Molecular Diagnostic Techniques; Prospective Studies; Pulmonary Aspergillosis; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity	2011
Breakthrough invasive mould infections in patients treated with caspofungin. The Journal of infection, 2012, Volume: 64, Issue:4 Topics: Adult; Aged; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; France; Fusariosis; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospitals, University; Humans; Lipopeptides; Male; Mannans; Middle Aged; Mucormycosis; Pulmonary Aspergillosis	2012
Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis. Medical mycology, 2012, Volume: 50, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aspergillus; Bronchoalveolar Lavage Fluid; Chronic Disease; Clinical Laboratory Techniques; Female; Galactose; Humans; Immunoenzyme Techniques; Japan; Male; Mannans; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Sensitivity and Specificity; Serum; Young Adult	2012
Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12 Topics: Animals; Antifungal Agents; Body Burden; C-Reactive Protein; Colony Count, Microbial; Cortisone; Drug Combinations; Galactose; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung; Mannans; Organ Size; Pulmonary Aspergillosis; Pyrimidines; Rats; Respiratory Function Tests; Serum Amyloid P-Component; Survival; Triazoles; Voriconazole	2012